Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.Published in:Human Molecular Genetics, 2016, v. 25, n. 20, p. 4590, doi. 10.1093/hmg/ddw290By:Strug, Lisa J.;Gonska, Tanja;Gengming He;Keenan, Katherine;Wan Ip;Boëlle, Pierre-Yves;Fan Lin;Panjwani, Naim;Jiafen Gong;Weili Li;Soave, David;Bowei Xiao;Tullis, Elizabeth;Rabin, Harvey;Parkins, Michael D.;Price, April;Zuberbuhler, Peter C.;Corvo, Harriet;Ratjen, Felix;Lei SunPublication type:Article